Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05396456

Autologous Muscle Fiber Fragment Injections

Autologous Muscle Fiber Fragment Injections for the Treatment of Fecal Incontinence

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To regenerate functional anal sphincter muscle using muscle fiber fragments that contain muscle precursor cells (MPCs)

Detailed description

The Study hypothesizes that efficient re-assembly of injected fragments within host muscle tissue along the fiber direction of native muscle will be induced. It is anticipated that these fiber fragments would integrate into the host vascular and neural network.

Conditions

Interventions

TypeNameDescription
PROCEDUREMuscle Fiber Fragment (MFF) InjectionsThe participant will be treated with an injection of muscle fiber fragments into the external anal sphincter at 3, 6, 9 and 12 o'clock using a 21-gauge needle to a depth of 1-2 cm from the external skin using equal amounts in each quadrant.

Timeline

Start date
2023-01-12
Primary completion
2029-12-01
Completion
2029-12-01
First posted
2022-05-31
Last updated
2026-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05396456. Inclusion in this directory is not an endorsement.

Autologous Muscle Fiber Fragment Injections (NCT05396456) · Clinical Trials Directory